West Pharmaceutical Services Inc (WST)
Net profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 593,400 | 559,400 | 518,700 | 552,100 | 585,900 | 630,600 | 685,600 | 684,400 | 661,800 | 612,500 | 519,200 | 423,100 | 346,200 | 311,700 | 285,700 | 260,600 | 241,700 | 229,800 | 228,700 | 218,700 |
| Revenue (ttm) | US$ in thousands | 2,931,600 | 2,918,300 | 2,862,000 | 2,884,600 | 2,888,000 | 2,911,600 | 2,929,000 | 2,882,500 | 2,833,200 | 2,681,100 | 2,521,700 | 2,320,600 | 2,141,400 | 2,030,200 | 1,941,400 | 1,887,900 | 1,839,900 | 1,791,800 | 1,767,400 | 1,745,200 |
| Net profit margin | 20.24% | 19.17% | 18.12% | 19.14% | 20.29% | 21.66% | 23.41% | 23.74% | 23.36% | 22.85% | 20.59% | 18.23% | 16.17% | 15.35% | 14.72% | 13.80% | 13.14% | 12.83% | 12.94% | 12.53% |
December 31, 2023 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $593,400K ÷ $2,931,600K
= 20.24%
West Pharmaceutical Services, Inc.'s net profit margin has shown a decreasing trend over the past four quarters, declining from 23.76% in Q1 2022 to 20.12% in Q4 2023. This trend indicates a potential decrease in profitability for the company during this period. Although the net profit margin has fluctuated slightly quarter to quarter, it has consistently remained above 18%, suggesting that the company has maintained a relatively healthy level of profitability despite the downward trend. Further analysis of the company's cost structure and revenue streams may be needed to understand the factors contributing to this trend in net profit margin.
Peer comparison
Dec 31, 2023